HUS2200041I1
(hu )
2022-09-28
Anti-CD3 antitestek és alkalmazási eljárások
IL263266A
(en )
2018-12-31
Anti hla-g specific antibodies
IL258909A
(en )
2018-06-28
Antibodies specifically binding pd-1 and their uses
IL251970B
(en )
2021-12-01
Anti-cd79b antibodies and methods of use
CL2016002462A1
(es )
2017-06-23
Anticuerpos anti-ox40 y métodos de uso
IL254039A0
(en )
2017-10-31
Anti-pvrig antibodies and methods of use
IL252811B
(en )
2021-10-31
Bispecific tetravalent antibodies and methods of makiing and using thereof
DK3353212T3
(da )
2021-12-20
Optimerede bispecifikke anti-CD3-antistoffer og anvendelser deraf
IL246382A0
(en )
2016-08-31
Antibody molecules to pd-1 and uses thereof
IL249092A0
(en )
2017-01-31
Anti-gitr antibodies and methods of use thereof
PT3215532T
(pt )
2019-12-18
Anticorpos anti-tim3 e métodos de utilização
HUE055465T2
(hu )
2021-11-29
PD-L1 ellenes humán antitestek
ME03675B
(me )
2020-10-20
Humanizovana ili himerna anтi-cd3 antiтela
CL2015002562A1
(es )
2016-03-04
Anticuerpos e inmunoconjugados anti-b7-h4
DK3026062T3
(da )
2020-10-12
Anti-pd-1-antistof og anvendelse deraf
CL2016001102A1
(es )
2017-02-10
Anticuerpos anti-claudina novedosos y métodos de uso.
HRP20181478T1
(hr )
2018-11-02
Humanizirani anti-cd134 (ox40) protutijela i njihove uporabe
DK3149042T3
(da )
2019-11-04
PD-L1-antistoffer og anvendelser deraf
DK3079719T3
(da )
2019-11-18
ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf
HRP20251683T1
(hr )
2026-02-13
Humanizirana anti-acth antitijela i njihova uporaba
DK3086807T3
(da )
2022-09-19
Antistoffer og fremgangsmåder til anvendelse
EP3212232A4
(en )
2019-01-23
TETRAVALENT TLR9 BISPECIFIC ANTIBODIES
EP3194438C0
(en )
2024-04-03
BMP4-BINDING ANTIBODIES, AND THEIR USES
HUE047455T2
(hu )
2020-04-28
HPA-1A elleni antitestek
TH1601003592A
(th )
2018-09-06
แอนติบอดีต่อต้าน cd3 และวิธีการใช้